Decreased Immunologically Active Molecule Activity [PE] - N0000008663
Pharmacologic Class Information
| Pharmacologic Code | N0000008663 |
| Pharmacologic Name | Decreased Immunologically Active Molecule Activity |
| Pharmacologic Concept | Physiologic Effects - [PE] |
| Pharmacologic Concept Description | This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept. |
NDC Products with Decreased Immunologically Active Molecule Activity
The table contains 4 products whose active ingredient are classified under the same pharmacologic class Decreased Immunologically Active Molecule Activity [PE].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 59572-205 | Thalomid | Non-Proprietary Name: Thalidomide | Capsule | Oral | Celgene Corporation | ACTIVE | |
| 59572-210 | Thalomid | Non-Proprietary Name: Thalidomide | Capsule | Oral | Celgene Corporation | ACTIVE | |
| 59572-215 | Thalomid | Non-Proprietary Name: Thalidomide | Capsule | Oral | Celgene Corporation | ACTIVE | |
| 59572-220 | Thalomid | Non-Proprietary Name: Thalidomide | Capsule | Oral | Celgene Corporation | ACTIVE |
